Literature DB >> 23574722

p63 regulates glutaminase 2 expression.

Arianna Giacobbe1, Lucilla Bongiorno-Borbone, Francesca Bernassola, Alessandro Terrinoni, Elke Katrin Markert, Arnold J Levine, Zhaohui Feng, Massimilano Agostini, Lello Zolla, Alessandro Finazzi Agrò, Daniel A Notterman, Gerry Melino, Angelo Peschiaroli.   

Abstract

The transcription factor p63 is critical for many biological processes, including development and maintenance of epidermal tissues and tumorigenesis. Here, we report that the TAp63 isoforms regulate cell metabolism through the induction of the mitochondrial glutaminase 2 (GLS2) gene both in primary cells and tumor cell lines. By ChIP analysis and luciferase assay, we confirmed that TAp63 binds directly to the p53/p63 consensus DNA binding sequence within the GLS2 promoter region. Given the critical role of p63 in epidermal differentiation, we have investigated the regulation of GLS2 expression during this process. GLS2 and TAp63 expression increases during the in vitro differentiation of primary human keratinocytes, and depletion of GLS2 inhibits skin differentiation both at molecular and cellular levels. We found that GLS2 and TAp63 expression are concomitantly induced in cancer cells exposed to oxidative stresses. siRNA-mediated depletion of GLS2 sensitizes cells to ROS-induced apoptosis, suggesting that the TAp63/GLS2 axis can be functionally important as a cellular antioxidant pathway in the absence of p53. Accordingly, we found that GLS2 is upregulated in colon adenocarcinoma. Altogether, our findings demonstrate that GLS2 is a bona fide TAp63 target gene, and that the TAp63-dependent regulation of GLS2 is important for both physiological and pathological processes.

Entities:  

Keywords:  colon carcinoma; glutaminolysis; p63; skin differentiation

Mesh:

Substances:

Year:  2013        PMID: 23574722      PMCID: PMC3674067          DOI: 10.4161/cc.24478

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  75 in total

Review 1.  Structure, function and regulation of p63 and p73.

Authors:  M Levrero; V De Laurenzi; A Costanzo; J Gong; G Melino; J Y Wang
Journal:  Cell Death Differ       Date:  1999-12       Impact factor: 15.828

2.  Glycolytic enzymes can modulate cellular life span.

Authors:  Hiroshi Kondoh; Matilde E Lleonart; Jesus Gil; Jing Wang; Paolo Degan; Gordon Peters; Dolores Martinez; Amancio Carnero; David Beach
Journal:  Cancer Res       Date:  2005-01-01       Impact factor: 12.701

3.  Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice.

Authors:  E Candi; A Rufini; A Terrinoni; D Dinsdale; M Ranalli; A Paradisi; V De Laurenzi; L G Spagnoli; M V Catani; S Ramadan; R A Knight; G Melino
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

Review 4.  Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer.

Authors:  R J DeBerardinis; T Cheng
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

5.  Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors.

Authors:  Toshiyuki Takeuchi; Shuta Tomida; Yasushi Yatabe; Takayuki Kosaka; Hirotaka Osada; Kiyoshi Yanagisawa; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  J Clin Oncol       Date:  2006-03-20       Impact factor: 44.544

6.  Induction of TAp63 by histone deacetylase inhibitors.

Authors:  Berna S Sayan; Ai Li Yang; Franco Conforti; Sergio Bernardini; Paola Tucci; Mariuca Vasa-Nicotera; Richard A Knight; Gerry Melino
Journal:  Biochem Biophys Res Commun       Date:  2009-12-30       Impact factor: 3.575

7.  Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73.

Authors:  A Petitjean; C Ruptier; V Tribollet; A Hautefeuille; F Chardon; C Cavard; A Puisieux; P Hainaut; C Caron de Fromentel
Journal:  Carcinogenesis       Date:  2007-11-28       Impact factor: 4.944

8.  Emerging concepts: linking hypoxic signaling and cancer metabolism.

Authors:  C A Lyssiotis; M G Vander-Heiden; M G V Heiden; C Muñoz-Pinedo; B M Emerling
Journal:  Cell Death Dis       Date:  2012-05-03       Impact factor: 8.469

9.  Mammalian glutaminase Gls2 gene encodes two functional alternative transcripts by a surrogate promoter usage mechanism.

Authors:  Mercedes Martín-Rufián; Marta Tosina; José A Campos-Sandoval; Elisa Manzanares; Carolina Lobo; J A Segura; Francisco J Alonso; José M Matés; Javier Márquez
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

10.  DeltaNp63 regulates thymic development through enhanced expression of FgfR2 and Jag2.

Authors:  Eleonora Candi; Alessandro Rufini; Alessandro Terrinoni; Alessandro Giamboi-Miraglia; Anna Maria Lena; Roberto Mantovani; Richard Knight; Gerry Melino
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-11       Impact factor: 11.205

View more
  42 in total

1.  Sustained protein synthesis and reduced eEF2K levels in TAp73-\- mice brain: a possible compensatory mechanism.

Authors:  Barak Rotblat; Massimiliano Agostini; Maria Victoria Niklison-Chirou; Ivano Amelio; Anne E Willis; Gerry Melino
Journal:  Cell Cycle       Date:  2018-12-04       Impact factor: 4.534

Review 2.  Two-way communication between the metabolic and cell cycle machineries: the molecular basis.

Authors:  Joanna Kaplon; Loes van Dam; Daniel Peeper
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Multi-omics profiling of calcium-induced human keratinocytes differentiation reveals modulation of unfolded protein response signaling pathways.

Authors:  Anna Michaletti; Mara Mancini; Artem Smirnov; Eleonora Candi; Gerry Melino; Lello Zolla
Journal:  Cell Cycle       Date:  2019-07-22       Impact factor: 4.534

4.  Gata6 promotes hair follicle progenitor cell renewal by genome maintenance during proliferation.

Authors:  Alex B Wang; Ying V Zhang; Tudorita Tumbar
Journal:  EMBO J       Date:  2016-12-01       Impact factor: 11.598

Review 5.  From Krebs to clinic: glutamine metabolism to cancer therapy.

Authors:  Brian J Altman; Zachary E Stine; Chi V Dang
Journal:  Nat Rev Cancer       Date:  2016-07-29       Impact factor: 60.716

Review 6.  Targeting amino acid metabolism for cancer therapy.

Authors:  Michael J Lukey; William P Katt; Richard A Cerione
Journal:  Drug Discov Today       Date:  2016-12-14       Impact factor: 7.851

Review 7.  Novel therapeutic targets of tumor metabolism.

Authors:  Rigel J Kishton; Jeffrey C Rathmell
Journal:  Cancer J       Date:  2015 Mar-Apr       Impact factor: 3.360

8.  Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis.

Authors:  Yan Xiang; Zachary E Stine; Jinsong Xia; Yunqi Lu; Roddy S O'Connor; Brian J Altman; Annie L Hsieh; Arvin M Gouw; Ajit G Thomas; Ping Gao; Linchong Sun; Libing Song; Benedict Yan; Barbara S Slusher; Jingli Zhuo; London L Ooi; Caroline G L Lee; Anthony Mancuso; Andrew S McCallion; Anne Le; Michael C Milone; Stephen Rayport; Dean W Felsher; Chi V Dang
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

Review 9.  Stress eating and tuning out: cancer cells re-wire metabolism to counter stress.

Authors:  Zachary E Stine; Chi V Dang
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-10-07       Impact factor: 8.250

Review 10.  Glutaminolysis as a target for cancer therapy.

Authors:  L Jin; G N Alesi; S Kang
Journal:  Oncogene       Date:  2015-11-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.